Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
Reinhard Bos(Johns Hopkins University), Elsken van der Wall(Johns Hopkins University), Gregg L. Semenza(Johns Hopkins University), Herbert M. Pinedo(Amsterdam University Medical Centers), Sybren Meijer(Amsterdam UMC Location Vrije Universiteit Amsterdam), Astrid E. Greijer(Amsterdam UMC Location VUmc), Petra van der Groep(Amsterdam UMC Location Vrije Universiteit Amsterdam), Avi Shvarts(Amsterdam UMC Location Vrije Universiteit Amsterdam), P. J. van Diest(University Medical Center Utrecht)
Cited by 499
Related Papers
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
|Genes & Development|2001|1.4k
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
|Journal of Clinical Investigation|2013|1.3k
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m <sup>6</sup> A-demethylation of NANOG mRNA
|Proceedings of the National Academy of Sciences|2016|1k
HIF-1 and human disease: one highly involved factor
|Genes & Development|2000|916
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834